Exim Routes IPO Subscription Status: IPO Subscribed 15.23 Times on Final Day  

Mumbai, 16 December 2025: The Exim Routes IPO Subscription status Details for the NSE SME book building issue showed full demand visibility by the close of Day 3, with the public issue subscribed 15.23 times. The subscription pattern reflected participation across investor categories, led by the non-institutional segment.

Exim Routes operates in the logistics and international trade services segment, offering solutions linked to cargo movement, documentation, and supply chain facilitation. The company is set to list on the NSE SME platform, aligning with its small and medium enterprise positioning.

Exim Routes IPO Subscription Status Closed at 15.23x on Final Day, with the NII Category leading the bids at 22.43x.

The Exim Routes IPO recorded an overall subscription status of 15.23 times on 16 December 2025 (Day 3). The public issue was subscribed 9.94 times in the individual investors category, 19.11 times in the Qualified Institutional Buyers (QIB) excluding anchor investors, and 22.43 times in the Non-Institutional Investors (NII) category. 

Anchor investors fully subscribed 14,11,200 shares, amounting to ₹12.419 crore, while the Market Maker portion of 2,49,600 shares was fully subscribed at ₹2.196 crore. The QIB segment received bids for 1,79,77,600 shares against 9,40,800 shares on offer, totalling ₹158.203 crore across 13 applications. 

NII bids stood at 1,59,31,200 shares versus 7,10,400 shares offered, including bNII (above ₹10 lakh) at 1,30,46,400 shares and sNII (below ₹10 lakh) at 28,84,800 shares, aggregating ₹140.195 crore. Individual investors applied for 1,64,70,400 shares against 16,57,600 shares on offer, amounting to ₹144.940 crore across 5,147 applications. 

Overall, the IPO received bids for 5,03,79,200 shares against 33,08,800 shares, totalling ₹443.337 crore across 6,701 applications.

Exim Routes IPO Subscription Status on Day 1 & 2

On Day 1 (12 December 2025), the issue was subscribed 0.51 times, with individual investors at 0.50 times and NIIs at 1.21 times. By Day 2 (15 December 2025), total subscription rose to 1.13 times, driven by NIIs at 2.64 times, while retail participation increased to 1.13 times. QIB participation remained absent on both days.

Key Details and Structure of IPO Exim Routes

Exim Routes IPO is a book build issue of ₹43.73 crores. The issue is entirely a fresh issue of 0.50 crore shares of ₹43.73 crore.

Exim Routes IPO bidding opened for subscription status on December 12, 2025, and closed today, December 16, 2025. The allotment for the Exim Routes IPO is expected to be finalised on Dec 17, 2025. Exim Routes IPO will list on NSE SME with a tentative listing date fixed as Dec 19, 2025.

Exim Routes IPO price band is set at ₹83.00 to ₹88.00 per share. The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹2,81,600.00 (3,200 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (4,800 shares), amounting to ₹4,22,400.

Narnolia Financial Services Ltd. is the book running lead manager and Maashitla Securities Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Nikunj Stock Brokers Ltd.

The IPO subscription status process now moves to the allotment and post-issue stages, which include finalisation of the basis of allotment, initiation of refunds for non-allotted applications, and credit of shares to successful bidders’ demat accounts. This will be followed by the listing of Exim Routes shares on the NSE SME platform, completing the public issue lifecycle.

Source : https://www.nseindia.com/market-data/issue-information?symbol=EXIMROUTES&series=SME&type=Active

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur. 

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com. 

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations